Xiaoxi Li

3.0k total citations
77 papers, 2.4k citations indexed

About

Xiaoxi Li is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Xiaoxi Li has authored 77 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Pharmacology. Recurrent topics in Xiaoxi Li's work include Advanced biosensing and bioanalysis techniques (18 papers), MicroRNA in disease regulation (9 papers) and RNA Interference and Gene Delivery (7 papers). Xiaoxi Li is often cited by papers focused on Advanced biosensing and bioanalysis techniques (18 papers), MicroRNA in disease regulation (9 papers) and RNA Interference and Gene Delivery (7 papers). Xiaoxi Li collaborates with scholars based in China, United States and Czechia. Xiaoxi Li's co-authors include Peng Miao, Limin Ning, Genxi Li, Yu Jiang, Fei Zhou, Cen Wu, Shuangge Ma, Jie Ren, Jian Yin and Shulan Sun and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoxi Li

76 papers receiving 2.4k citations

Peers

Countries citing papers authored by Xiaoxi Li

Since Specialization

Citations

This map shows the geographic impact of Xiaoxi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Li more than expected).

Fields of papers citing papers by Xiaoxi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Li. The network helps show where Xiaoxi Li may publish in the future.

Co-authorship network of co-authors of Xiaoxi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxi Li. A scholar is included among the top collaborators of Xiaoxi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxi Li. Xiaoxi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of immunogenic cell death and potential applications in cancer therapy 2025 ·Frontiers in Immunology ·(unknown), Shuai Yuan, Xue Zhang, Jingdong Zhang, Shulan Sun, Xiaoxi Li	6
2	Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results 2024 ·Nature Medicine ·Jerry R. Mendell, Eric R. Pozsgai, Sarah Lewis, Danielle A. Griffin, Linda Lowes, Lindsay N. Alfano, Kelly J. Lehman, Kathleen Church, Natalie F. Reash, M. Iammarino, (unknown), Rachael A. Potter, Sarah Neuhaus, Xiaoxi Li, (unknown), Louise R. Rodino‐Klapac	9
3	Global trends and risk factors in gastric cancer: a comprehensive analysis of the Global Burden of Disease Study 2021 and multi-omics data 2024 ·International Journal of Medical Sciences ·(unknown), Qian Dong, Yuanhe Wang, Xiaoxi Li, (unknown), (unknown), Jingdong Zhang	2
4	Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a/b-3p/HBEGF axis 2023 ·Cancer Cell International ·Xiaojuan Huang, Yan Wang, Hui‐Ting Wang, Zhaofeng Liang, Cheng Ji, Xiaoxi Li, Leilei Zhang, Runbi Ji, Wenrong Xu, Jianhua Jin, Hui Qian	15
5	Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma 2022 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), Ke Wang, Xiaoxi Li, Lan Zhang, Xian‐Zhe Dong	6
6	Deduction of CDC42EP3 suppress development and progression of osteosarcoma 2022 ·Experimental Cell Research ·Peng Xu, Xiaoxi Li, (unknown), (unknown), Jiaming Xu	6
7	Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer 2021 ·Cancer Communications ·Shulan Sun, Wei Zhou, Xiaoxi Li, Fei Peng, Min Yan, (unknown), Fan An, Xiaoyan Li, Yunyong Liu, Quentin Liu, Haozhe Piao	33
8	Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression 2021 ·Molecular and Cellular Biochemistry ·Meng Wang, (unknown), Xiaoxi Li, Shulan Sun, (unknown)	6
9	MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis 2021 ·Cancer Management and Research ·Jian Zheng, Xiaoxi Li, (unknown), (unknown), Bin Zhang	13
10	Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine 2020 ·Cells ·Lei Yin, (unknown), Ying‐Hong Shi, Dickson Kofi Wiredu Ocansey, Yu‐Yan Hu, Xiaoxi Li, Chenxiao Zhang, Wenrong Xu, Hui Qian	67
11	Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi Rebalance Bone Remodeling in Ovariectomized Rats 2019 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Xiaoxi Li, Xiufeng Tang, (unknown), (unknown), Liping Xu, Renhui Liu	11
12	Active Ingredients of Epimedii Folium and Ligustri Lucidi Fructus Balanced GR/HSP90 to Improve the Sensitivity of Asthmatic Rats to Budesonide 2017 ·Evidence-based Complementary and Alternative Medicine ·Xiufeng Tang, Xiaoxi Li, (unknown), Yan Yang, (unknown), Xiujuan Wang, Liping Xu, Xinwei Yang, Renhui Liu	7
13	Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin 2017 ·Oncology Reports ·Xiaoxi Li, Hong Wang, (unknown), (unknown), Jingwen Jiang, (unknown), Xiaobing Guo, (unknown), Cuiqing Ma	23
14	Case report: anesthesia management for emergency cesarean section in a patient with dwarfism 2015 ·BMC Anesthesiology ·Xiaoxi Li, (unknown), Mingzhang Zuo	9
15	Colorimetric assay for protein detection based on “nano-pumpkin” induced aggregation of peptide-decorated gold nanoparticles 2015 ·Biosensors and Bioelectronics ·(unknown), Xiaoying Wang, Chao Li, Xiaoxi Li, Yongmei Yin, Genxi Li	50
16	Malibatol A protects against brain injury through reversing mitochondrial dysfunction in experimental stroke 2014 ·Neurochemistry International ·Wenjie Yang, Xiang Chen, Jie Pan, Hui Ming Ge, Kailin Yin, Zhenhua Wu, Xiaoxi Li, Dujuan Sha, Yun Xu	35
17	Gypenosides Induce Apoptosis by Ca ²⁺ Overload Mediated by Endoplasmic-Reticulum and Store-Operated Ca ²⁺ Channels in Human Hepatoma Cells 2013 ·Cancer Biotherapy and Radiopharmaceuticals ·Dapeng Sun, Xiaoxi Li, Xinli Liu, Dan Zhao, (unknown), Yan Li, Ping Ma	19
18	Transcriptional activation of flavan-3-ols biosynthesis in grape berries by UV irradiation depending on developmental stage 2013 ·Plant Science ·Zhenzhen Zhang, (unknown), Qiu‐Hong Pan, Xiaoxi Li, Chang‐Qing Duan	45
19	Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation 2013 ·European Journal of Endocrinology ·Yongbo Huang, (unknown), Lingxiao Pan, Runyi Ye, Xiaoxi Li, Shenming Wang, Caisheng Ye, Liuhua Chen	39
20	Down‐regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells 2009 ·Cancer Science ·Jun Li, Liang Yu, Huizhong Zhang, Jueheng Wu, Jie Yuan, Xiaoxi Li, Mengfeng Li	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact